Format

Send to

Choose Destination
Nat Rev Urol. 2012 Feb 28;9(3):124. doi: 10.1038/nrurol.2012.25.

Prostate cancer: β-Catenin:androgen receptor ratio could guide personalized CRPC treatment in men with bone metastases.

PMID:
22370544
DOI:
10.1038/nrurol.2012.25

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center